Viva Biotech Holdings (1873.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.78B |
| Enterprise Value | 4B |
| P/E Ratio | 13.52 |
| PEG Ratio | 15.72 |
| Price/Sales Ratio | 1.21 |
| Price/Book Ratio | 0.59 |
| Enterprise/Revenue | 1.14 |
| Enterprise/EBITDA | 5.49 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.1 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 1.73B |
| Revenue/Share | 0.9 |
| Gross Profit | 655.56M |
| EBITDA | 404.3M |
| Net Income | 219.76M |
| Diluted EPS | 0.09 |
Balance Sheet
| Total Cash | 1.06B |
| Total Cash/Share | 0.5 |
| Total Debt | 897.96M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 1.52 |
| Book Value Per Share | 1.89 |
Price History
| 52-Week Change | -46.52 |
| 52-Week High | 2.86 |
| 52-Week Low | 1.04 |
| Moving Average 50 Days | 1.45 |
| Moving Average 200 Days | 1.67 |
Statistics
| Average Volume | 5.8M |
| Shares Outstanding | 2.07B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
